Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis



Status:Recruiting
Conditions:Arthritis, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Rheumatology
Healthy:No
Age Range:Any - 17
Updated:10/17/2018
Start Date:July 15, 2016
End Date:July 2020
Contact:Grace Wang, BA
Email:wangg@hss.edu
Phone:212-774-2121

Use our guide to learn which trials are right for you!

Differentiating between septic arthritis and other causes of joint inflammation in pediatric
patients is challenging and of the utmost importance because septic arthritis requires
surgical debridement as part of the treatment regimen. The current gold standard to diagnose
septic arthritis in children is a positive synovial fluid culture; however, joint cultures
may take several days to return. If a bacterial infection is present, it requires immediate
surgical intervention in order to prevent lasting articular cartilage damage. Frequently
surgeons must decide whether to surgically debride a joint before culture results are
available. There is no single lab test or clinical feature that reliably indicates bacterial
infection over other causes of joint inflammation. The alpha-defensin assay has shown high
sensitivity and specificity for joint infection in other studies.The purpose of this study is
to determine the sensitivity and specificity of several synovial biomarkers for diagnosing
pediatric septic arthritis.

The purpose of this study is to determine if alpha-defensin and other proteins present in
joint fluid may be able to rapidly diagnose bacterial joint infections. Patients with
suspected joint infection typically undergo joint aspiration so that tests can be performed
to help diagnose joint infection, including gram stain, cell count, and culture. Patients
under 18 years old that are undergoing sampling of their joint fluid due to suspicion of
infection or inflammation will be enrolled in this multi-center trial. Joint fluid will also
be sampled from normative controls made up of patients who are undergoing an unrelated
procedure without inflammation or infection. Joint fluid from patients with suspected
inflammation/infection and from normative controls will be analysed for presence of
alpha-defensin, leukocyte esterase, neutrophil elastase, synovial C-reactive protein, and
synovial lactate. The alpha-defensin assay has shown high sensitivity and specificity for
joint infection in other studies. Additionally a Staphylococcus spp antigen panel, Candida
spp antigen panel, Enterococcus faecalis assay, BACTAlert culture, cell count plus
differential, gram stain, and aerobic, anaerobic, and fungal cultures will be done using
synovial fluid. A synovial fluid PCR for Kingella kingae will be performed if the patient is
under eight years of age. Blood tests will include cell count and differential, erythrocyte
sedimentation rate, C-reactive protein, procalcitonin, and D-dimer, as well as relevant
inflammatory or rheumatologic marker tests. Results from these tests will be compared to
joint fluid culture which the gold standard for diagnosing bacterial infection. The study
includes 1 visit per patient, the standard of care visit in which the patient would be
undergoing joint aspiration or arthroscopy. Once data has been collected, the sensitivity and
specificity will be determined for these experimental tests both individually and in
combination.

Inclusion Criteria- Septic Cases and Inflamed, Non-Septic Comparators:

- Synovial fluid is obtained to assess for infection or inflammatory/rheumatologic
disease (all medium and large joints will be included: hip, knee, ankle, shoulder,
subtalar, elbow, and wrist joints)

- Patients with recent antibiotic exposure are eligible to participate but will be
analyzed separately

Inclusion Criteria- Normative Controls:

- Patients undergoing a procedure unrelated to infection (the procedure may be
arthroscopy, or an open or percutaneous bony or soft tissue procedure)

Exclusion Criteria- All Participants:

- Family declines to participate/consent

- Patients with a major joint trauma (such as a documented ligament tear or fracture)
within the past 8 weeks are not eligible to have that joint aspirated, but could have
another joint aspirated

Exclusion Criteria- Normative Controls:

- A history of recent infection (within the past 3 months)

- Received antibiotics in the past 7 days
We found this trial at
3
sites
535 E 70th St
New York, New York 10021
(212) 606-1000
Principal Investigator: Emily R Dodwell, MD, MPH
Phone: 212-774-2121
Hospital for Special Surgery Founded in 1863, Hospital for Special Surgery is the nation
?
mi
from
New York, NY
Click here to add this to my saved trials
1405 Clifton Road NE
Atlanta, Georgia 30322
404-785-6000
Phone: 678-686-6864
Children's Healthcare of Atlanta Whether treating a toddler in an emergency or supporting a teen...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Collierville, Tennessee 38017
Phone: 901-287-5413
?
mi
from
Collierville, TN
Click here to add this to my saved trials